SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of Cardiology

[Return To Index page]
photo Matthew E. Harinstein, MD, FACC, FASE

Assistant Professor of Medicine

Vice President Medical Affairs/Chief Medical Officer, UPMC McKeesport

Email: harinsteinme@upmc.edu

Phone: 412-664-4124

Contact
Office: 1668 Lincoln Way
White Oak, PA 15131
 
Phone: 412-664-4124
Fax:
E-mail: harinsteinme@upmc.edu
Administrative Assistant:
Lynn DiCenzo
Email: dicenzola@upmc.edu
Phone: 412-664-2301
Fax: 412-664-2600
Education and Training
Education
MD, Loyola University Chicago, 2006
Training
Internal Medicine Residency, Northwestern University, 2009
Cardiology Fellowship, University of Pittsburgh Medical Center, 2012
Research Interest
Dr. Harinstein's areas of interest include acute heart failure syndromes, transcatheter aortic valve replacement outcomes, assessment of right ventricular function in liver transplant candidates, cardiac risk assessment of solid organ transplant candidates, clinical trials studying new pharmacologic agents, and assessment of mechanical dyssynchrony with gated SPECT. He also is a reviewer and member of the editorial board of American Journal of Cardiology.
Clinical Interest
Dr. Harinstein spends his clinical time at UPMC McKeesport, UPMC Shadyside and UPMC Presbyterian hospitals. He cares for patients with all aspects of cardiovascular disease. He has a special emphasis on non-invasive imaging including echocardiography (transthoracic, transesophageal, and stress) and nuclear cardiology. He is also a member of the structural heart group/transcatheter aortic valve replacement team specializing in imaging of structural heart disease with a particular emphasis on transcatheter valve replacement and three-dimensional imaging techniques. He is board certified in internal medicine, cardiovascular disease, echocardiography, nuclear cardiology, cardiovascular computed tomography and is a registered physician of vascular interpretation.
Publications
Selected Publications:
Harinstein ME, Soman P. Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure. Curr Cardiol Rep. 2016; 18(3): 23.
Cavalcante JL, Rijal S, Althouse AD, Delgado-Montero A, Katz WE, Schindler JT, Crock F, Harinstein ME, Navid F, Gleason TG, Lee JS. Right Ventricular Function and Prognosis in Patients with Low-Flow, Low-Gradient Severe Aortic Stenosis. J Am Soc Echocardiogr. 2016; 29(4): 325-33.
Harinstein ME, Butler J, Greene SJ, Fonarow GC, Stockbridge NL, O'Connor CM, Pfeffer MA, Mehra MR, Solomon SD, Yancy CW, Fiuzat M, Mentz RJ, Collins SP, McMurray JJ, Vaduganathan M, Dunnmon PM, Rosano GM, Dinh W, Misselwitz F, Bonow RO, Gheorghiade M. Site selection for heart failure clinical trials in the USA. Heart Fail Rev. 2015; 20(4): 375-83.
Greene SJ, Vaduganathan M, Wilcox JE, Harinstein ME, Maggioni AP, Subacius H, Zannad F, Konstam MA, Chioncel O, Yancy CW, Swedberg K, Butler J, Bonow RO, Gheorghiade M, EVEREST Trial Investigators. The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. JACC Heart Fail. 2013; 1(6): 488-96.
Harinstein ME, Iyer S, Mathier MA, Flaherty JD, Fontes P, Planinsic RM, Edelman K, Katz WE, Lopez-Candales A. Role of baseline echocardiography in the preoperative management of liver transplant candidates. Am J Cardiol. 2012; 110(12): 1852-5.
Greene SJ, Harinstein ME, Vaduganathan M, Subacius H, Konstam MA, Zannad F, Maggioni AP, Swedberg K, Butler J, Gheorghiade M, EVEREST Trial Investigators. Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Am J Cardiol. 2012; 110(11): 1657-62.
Harinstein ME, Flaherty JD, Fonarow GC, Mehra MR, Lang RM, Kim RJ, Cleland JG, Knight BP, Pang PS, Bonow RO, Gheorghiade M. Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period. Heart. 2011; 97(19): 1607-18.
Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, Fix OK, Kay N, Abecassis MI, Gheorghiade M, Flaherty JD. Raval Z, Harinstein ME, Skaro AI, Erdogan A, DeWolf AM, Shah SJ, Fix OK, Kay N, Abecassis MI, Gheorghiade M, Flaherty JD. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011; 58(3): 223-31.
Harinstein ME, Flaherty JD, Ansari AH, Robin J, Davidson CJ, Rossi JS, Flamm SL, Blei AT, Bonow RO. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. American Journal of Transplantation. 2008; 8: 1523-8.
Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. American Heart Journal. 2009; 158(3): 437-43.
Notable Achievements
Vice President Medical Affairs/CMO, UPMC McKeesport, 2017
Director, Non-invasive Imaging, UPMC Shadyside, 2016
Chief, Cardiology, UPMC McKeesport, 2015
Fellow, American Society of Nuclear Cardiology, 2015
Member, Leadership Development Program, ASNC, 2014
Editorial Board Member, American Journal of Cardiology, 2014
Fellow, ASE, 2013
Fellow, ACC, 2013